Rigel Pharmaceuticals Financials

Values in thousands	2026-09-30	2026-06-30	2026-03-31	2025-12-31
Revenue	$80,890	$78,703	$58,818	$69,802
Gross Profit	70,107	70,178	54,212	63,847
EBITDA	19,459	25,212	13,687	25,014
EBIT	17,666	24,364	13,090	24,413
Net Income	13,185	17,290	8,654	268,065
Net Change In Cash	80,890	78,703	58,818	69,802
Free Cash Flow	34,564	30,653	2,725	21,992
Cash	46,646	60,816	24,411	40,580
Basic Shares	20,439	19,570	19,686	18,840

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$294,282	$179,278	$116,882	$120,242
Gross Profit	274,661	160,631	109,772	118,493
EBITDA	131,562	28,512	-16,981	-53,868
EBIT	129,147	26,284	-18,219	-54,866
Net Income	367,024	17,485	-25,091	-58,573
Net Change In Cash	294,282	179,278	116,882	120,242
Cost of Revenue				5,569
Free Cash Flow	75,655	31,075	-20,743	-74,208
Cash	40,580	56,746	32,786	24,459
Basic Shares	18,840	17,687	17,401	17,240